Cholinergic mechanisms related to REM sleep. III. Tonic and phasic inhibition of monosynaptic reflexes induced by an anticholinesterase in the decerebrate cat.
The depression of the postural activity induced by intravenous injection of eserine sulphate (0.1 mg/kg), an anticholinesterase, has been studied in precollicular decerebrate cats. The extensor and flexor monosynaptic reflexes elicited by single shock stimulation of the GS, P1-FDHL and DP nerves are tonically depressed during the episodes of postural atonia induced by the anticholinesterase. A further phasic depression of the monosynaptic reflexes occurs during the bursts of rapid eye movements (REM) typical of these episodes. These changes in spinal reflex activity closely resemble the tonic depression of the spinal reflexes described in the unrestrained cats during the desynchronized sleep as well as the phasic depression of the spinal reflexes characteristic of the hypnic bursts of REM. Results obtained after spinal cord section indicate that both the tonic and the phasic depression of the spinal reflexes induced by eserine are due to active inhibitory influences originating from supraspinal structures. A complete bilateral destruction of the vestibular nuclei or limited to the medial and descending vestibular nuclei abolishes not only the cholinergically induced bursts of REM, as reported in a previous paper, but also the related phasic depression of the monosynaptic reflexes. These findings can be related with previous observations showing that a bilateral lesion of the vestibular nuclei abolishes the REM bursts of desynchronized sleep, as well as the related phasic inhibition of the spinal reflexes. The tonic depression of the monosynaptic reflexes induced by the anticholinesterase, on the other hand, remains unmodified by this vestibular lesion. This depression, therefore, can be attributed to supraspinal descending inhibitory volleys originating from extravestibular structures.
Seguin
J J
JJ
Istituto di Fisiologia Umana, Cattedra II, Università di Pisa, Italia.
Magherini
P C
PC
Pompeiano
O
O
D000109:Acetylcholine / Q000502:physiology*; D000818:Animals; D002415:Cats; D002800:Cholinesterase Inhibitors / Q000494:pharmacology*; D003655:Decerebrate State / Q000503:physiopathology*; D005133:Eye Movements / Q000502:physiology; D009046:Motor Neurons / Q000502:physiology; D009127:Muscle Rigidity / Q000503:physiopathology; D010830:Physostigmine / Q000494:pharmacology*; D012023:Reflex, Monosynaptic / Q000187:drug effects*; D012895:Sleep, REM / Q000502:physiology*; D014726:Vestibular Nuclei / Q000293:injuries / Q000502:physiology* / Q000503:physiopathology
D002800:Cholinesterase Inhibitors; D010830:Physostigmine; D000109:Acetylcholine